Literature DB >> 3426795

Long-term analgesic reaction in attacked mice.

B Siegfried1, H R Frischknecht, G Riggio, P G Waser.   

Abstract

Four experiments were designed to characterize long-term analgesic (LTA) reaction in attacked mice. In Experiment 1 we showed that analgesic reaction in DBA mice, induced by the stress of being attacked (30 or 50 bites), is reinstated upon reexposure to seven bites 24 hr later. The magnitude of the LTA response depended on the level of analgesia on Day 1 and was smaller than the original response. In Experiment 2 we showed that LTA was prevented by naloxone or beta-chlornaltrexamine given before exposure (50 bites) on Day 1. Results of Experiment 3 revealed that naloxone or beta-chlornaltrexamine injected before reexposure to seven bites on Day 2 antagonized LTA measured 10 min, but not 1 min, after reexposure. In Experiment 4 we showed that morphine substituted for being attacked on Day 1 failed to produce LTA. We concluded that pain inhibitory mechanisms remain in a state of increased readiness for at least 24 hr after attack stress and that activation of opioid systems is necessary but not sufficient to produce LTA, a response that is only partly sensitive to opioid antagonists.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426795     DOI: 10.1037//0735-7044.101.6.797

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  3 in total

1.  Aggression modulates genetic influences on morphine analgesia as assessed using a classical mendelian cross analysis.

Authors:  L L Miner; G I Elmer; J O Pieper; R J Marley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 2.  Opioids and behavior: genetic aspects.

Authors:  H R Frischknecht; B Siegfried; P G Waser
Journal:  Experientia       Date:  1988-06-15

3.  A trouble shared is a trouble halved: social context and status affect pain in mouse dyads.

Authors:  Laura Gioiosa; Flavia Chiarotti; Enrico Alleva; Giovanni Laviola
Journal:  PLoS One       Date:  2009-01-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.